即刻药物复律与延迟复律对老年急性阵发性房颤病人预后的影响

doi:10.3969/j.issn.1003-9198.2024.12.017

Abstract

Abstract: Objective To analyze the effects of immediate drug conversion and delayed spontaneous conversion on the short-term prognosis in the elderly patients with paroxysmal atrial fibrillation (AF) admitted to the emergency department. Methods A retrospective analysis was conducted on the clinical data of 48 patients with paroxysmal AF admitted to Emergency Department of Jiangsu Province Official Hospital from January 2020 to October 2022. The patients were divided into the immediate drug conversion group and the delayed spontaneous conversion group according to the treatment method. The duration of AF, recurrence rate of AF within 4 weeks and the incidence rate of adverse events related to conversion were compared between the two groups. Results There were no significant statistical differences in the duration of AF and recurrence rate of AF within 4 weeks between the immediate drug conversion group and the delayed spontaneous conversion group (P>0.05). However, more patients in the immediate drug conversion group experienced chronic arrhythmia (29.17% vs 4.17%). Conclusions Immediate drug conversion may not be optimal for all paroxysmal AF; Instead, delayed spontaneous cardioversion can provide opportunities for spontaneous recovery while minimizing proarrhythmic effects associated with antiarrhythmic drugs.

Key words: paroxysmal atrial fibrillation, acute drug cardioversion, delayed spontaneous cardioversion, short-term prognosis

CLC Number:

R 541.75

LI Yuqiao, CHEN Min, WANG Leilei, ZHOU Weihua. Effects of immediate drug cardioversion and delayed cardioversion on prognosis in elderly patients with acute paroxysmal atrial fibrillation[J]. Practical Geriatrics, 2024, 38(12): 1266-1269.

References

[1] 马长生. 房颤的流行病学进展[J]. 医学与哲学(B),2016,37(11):8-9,26.
[2] WEIGNER M J, CAULFIELD T A, DANIAS P G, et al. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation of less than 48 hours[J]. Ann Intern Med, 1997, 126(8):615-620.
[3] PRYSTOWSKY E N, BENSON D W Jr, FUSTER V, et al. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association[J]. Circulation, 1996, 93(6):1262-1277.
[4] ALBERS G W, DALEN J E, LAUPACIS A, et al. Antithrombotic therapy in atrial fibrillation[J]. Chest, 2001, 119(1 Suppl):194S-206S.
[5] WYNN G J, TODD D M, WEBBER M,et al.The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification[J].Europace,2014,16(7): 965-972.
[6] GALVE E, RIUS T, BALLESTER R, et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study[J].J Am Coll Cardiol,1996,27(5):1079-1082.
[7] NOC M, STAJER D, HORVAT M. Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm[J]. Am J Cardiol, 1990, 65(9):679-680.
[8] COTTER G, BLATT A, KALUSKI E, et al. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study[J]. Eur Heart J, 1999, 20(24):1833-1842.
[9] GELERIS P, STAVRATI A, AFTHONIDIS D, et al. Spontaneous conversion to sinus rhythm of recent (within 24 hours) atrial fibrillation[J]. J Cardiol, 2001, 37(2):103-107.
[10] DOYLE B, REEVES M. “Wait and see” approach to the emergency department cardioversion of acute atrial fibrillation[J]. Emerg Med Int, 2011, 2011:545023.
[11] CAPUCCI A, COMPAGNUCCI P. Is delayed cardioversion the better approach in recent-onset atrial fibrillation? No[J]. Intern Emerg Med, 2020, 15(1):5-7.
[12] CAPRANZANO P, CALVI V. Timing of cardioversion in atrial fibrillation: the sooner the better?[J]. Eur Heart J Suppl, 2020, 22(Suppl L):L41-L43.
[13] DUDINK E, ESSERS B, HOLVOET W,et al. Acute cardioversion vs a wait-and-see approach for recent-onset symptomatic atrial fibrillation in the emergency department: Rationale and design of the randomized ACWAS trial[J]. Am Heart J, 2017, 183:49-53.
[14] PLUYMAEKERS N A H A, DUDINK E A M P, LUERMANS J G L M. Early or delayed cardioversion in recent-onset atrial fibrillation. Reply[J]. N Engl J Med, 2019, 380(16):1499-1508.
[15] BOTTO G L, TORTORA G. Is delayed cardioversion the better approach in recent-onset atrial fibrillation? Yes[J].Intern Emerg Med, 2020, 15(1):1-4.
[16] 董福强,霍宁. 房颤的发病机制研究及其中西医结合治疗进展[J]. 天津中医药, 2021, 38(8):1083-1088.

Effects of immediate drug cardioversion and delayed cardioversion on prognosis in elderly patients with acute paroxysmal atrial fibrillation

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 2

Metrics

Recommended 10

[1]	XIA Jing-ying, ZHANG Qian. Predictive value of geriatric nutritional risk index combined with PCTc and NLR for short-term prognosis in elderly patients with sepsis [J]. Practical Geriatrics, 2023, 37(2): 134-137.
[2]	SHI Yun-tao, WANG Lian, XIE Jun. Risk factors for persistent atrial fibrillation in patients with heart failure with reducesd ejection fraction [J]. Practical Geriatrics, 2021, 35(3): 254-256.